Skip to main content
SpringerLink
Log in

Osteoinductive bone graft substitutes

  • Original article
  • Published:
European Spine Journal Aims and scope Submit manuscript

Abstract

This review will summarize the major efforts currently underway to develop osteoinductive bone graft substitutes for minimally invasive spine fusions. The primary categories of substitute include purified bone growth factors, recombinant bone growth factors, and growth factors delivered by gene therapy approaches. Clinical trials are underway for the purified and recombinant bone growth factors and pre-clinical studies have yielded promising results for a variety of gene therapy techniques for generating bone.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Author information

Authors and Affiliations

  1. The Emory Spine Center, Emory University School of Medicine, Atlanta, Georgia, USA, , , , , , US

    S. C. Ludwig, J. M. Kowalski & S. D. Boden

Authors
  1. S. C. Ludwig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. J. M. Kowalski
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. S. D. Boden
    View author publications

    You can also search for this author in PubMed Google Scholar

Additional information

Received: 4 August 1999 /Accepted: 26 August 1999

Rights and permissions

Reprints and permissions

About this article

Cite this article

Ludwig, S., Kowalski, J. & Boden, S. Osteoinductive bone graft substitutes. E Spine J 9 (Suppl 1), S119–S125 (2000). https://doi.org/10.1007/PL00008317

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/PL00008317

Search

Navigation